Imaging in head and neck cancer.

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• Accurate imaging is crucial for head and neck cancer diagnosis, staging, and treatment monitoring.
• Distinguishing recurrent tumors from post-treatment changes is a significant challenge.

Purpose of the Study:

• To outline the roles of various imaging modalities in evaluating head and neck cancers.
• To compare the effectiveness of MRI, CT, and PET scans for different tumor types and stages.

Main Methods:

• Review of current imaging techniques for head and neck cancers.
• Comparison of MRI, CT, and PET/CT performance based on tumor location and characteristics.
• Discussion of imaging for recurrent disease and post-treatment assessment.

Main Results:

• MRI is preferred for nasopharyngeal, sinonasal, parotid, intraorbital, and intracranial tumors due to superior contrast and reduced artifacts.
• CT is often used for oropharyngeal, laryngeal, and hypopharyngeal tumors, being less susceptible to motion artifacts.
• MRI excels in detecting bone marrow invasion in oral cavity tumors.
• PET is highly sensitive for metastatic lymph nodes (≥8 mm) and superior for evaluating treated head and neck cancer.
• Combined PET/CT minimizes false positives/negatives.

Conclusions:

• The choice of imaging modality depends on tumor location and specific diagnostic questions.
• MRI and CT play complementary roles in initial tumor assessment.
• PET and PET/CT are valuable for detecting metastatic disease and evaluating treatment response, particularly in complex or recurrent cases.